analyst.andrewlengly.com/studies/oura-and-whoop :: oura and whoop
# Does paying for a wearable change how people live? US wearable use rose from 30.2% to 41.1% between 2020 and 2024 while the share meeting the activity guideline moved 0.1 points. A data study by Andrew Leng Ly.
designed page ......... analyst.andrewlengly.com/studies/oura-and-whoop
OURA AND WHOOP
analyst work .......... /machine/analyst data study ............ October 2026 question .............. Does paying for a wearable change how people live? headline finding ...... From 2020 to 2024 the share of US adults using a wearable rose from 30.2% to 41.1%, and the share meeting the aerobic activity guideline went from 47.9% to 48.0%. Oura keeps 85% of paid members for a year. I found no figure in the coverage of its IPO filing for whether members sleep or move more. my recommendation ..... Turn Advisor into a weekly plan and publish the share of members whose sleep or activity improved after 90 days. tools ................. CSV tables with a source URL on every row · JavaScript on Node for the derived rates · D3.js for the first dashboard · React and SVG for the charts on this page
THE QUESTION
the client ............ Oura’s leadership. Oura postponed its IPO on September 29, 2026, with 5.7 million paid members and 90% revenue growth expected for fiscal 2026. Whoop is the comparison, a band sold only with a membership, with more than 2.5 million members. the decision they face What should Oura build and report so that tracking turns into a lasting change in how members sleep and move?
THE DATA, 2 TABLES FROM 39 SOURCES
[01] metrics.csv ................................................................... 74 rows /studies/oura-and-whoop/data/metrics.csv Every figure in the study, one per row. It covers growth at Oura, Whoop and Garmin, US surveys of wearable use and activity, trial results on activity and sleep, and three Duolingo rows that tie back to my streaks study. where it came from Press coverage of Oura’s S-1, company press releases, Garmin’s SEC 8-K filings, Pew, the HINTS and NHIS surveys, and peer-reviewed meta-analyses. why i chose it ... Each figure has an ID and a source URL, so the code and a reader can go to the exact row. what it cannot tell us What happens to one person. The survey rows are population totals, and the trial rows are results I took from published papers. The Oura rows cite press coverage of the S-1, and none cites the filing directly. [02] variables.csv .................................................................. 6 rows /studies/oura-and-whoop/data/variables.csv Six product features scored 0 to 2 for Oura, Whoop, Apple Watch, Fitbit and Garmin. where it came from My own coding from product pages and press releases as of October 2026, with a link to the research behind each feature. why i chose it ... It puts Oura next to Whoop feature by feature. Oura totals 7 of 12 and Whoop 11, and the options aim at the gaps. what it cannot tell us Stand as measurement. The scores are judgment, and each row links its research so a reader can disagree. The table holds no URL for the product pages I read. # The 39 sources behind metrics.csv metrics.csv holds figures from 39 sources. Each one is listed with the rows it supplies and what they cover. 19 of them carry figures a company reported about itself. - Oura S-1 via BeInCrypto 3 rows · growth A company’s own figures - Oura S-1 via Healthcare Dive 1 row · growth A company’s own figures - Oura S-1 via TechRepublic 3 rows · growth A company’s own figures - Oura press release, Business Wire 2 rows · growth A company’s own figures - Oura S-1 via EBC 4 rows · growth, engagement A company’s own figures - Fierce Healthcare 1 row · growth A company’s own figures - Oura S-1 via SGB Media 1 row · engagement A company’s own figures - Oura S-1 via IPO Scoop 1 row · engagement A company’s own figures - MedTech Dive 1 row · valuation - Forbes Australia (Reuters calculation) 1 row · valuation - Front Office Sports 1 row · valuation - Digital Health News 1 row · pricing A company’s own figures - NPR via WUNC 1 row · engagement A company’s own figures - Oura press release via Silicon UK 1 row · engagement A company’s own figures - Bloomberg 2 rows · growth A company’s own figures - Dealroom 3 rows · growth, valuation 1 of 3 rows are a company’s own figures - Sacra 1 row · pricing A company’s own figures - Garmin 8-K Ex. 99.1, FY2024 results 2 rows · growth A company’s own figures - Garmin 8-K Ex. 99.1, FY2025 results 1 row · growth A company’s own figures - Garmin 8-K, FY2025 results 1 row · growth A company’s own figures - Tom's Guide 1 row · pricing A company’s own figures - Pew Research Center 3 rows · wearable use - HINTS via Pedroso et al. 2026 6 rows · wearable use - HINTS 6 via JMIR 2025 1 row · wearable use - Endeavour Partners via MobiHealthNews 1 row · abandonment - Endeavour Partners via NBC News 1 row · abandonment - Gartner via arXiv 1904.07986 1 row · abandonment - NHIS via Healthy People 2030 PA-02 2 rows · activity guideline - NCHS Data Brief 555 1 row · activity guideline - Ferguson et al. 2022, Lancet Digital Health 3 rows · trial outcomes - Ferguson et al. 2022 via Patient Care 3 rows · trial outcomes - Monninghoff et al. 2021, JMIR 6 rows · effects after a program ends - Brickwood et al. 2019, JMIR mHealth 4 rows · tracker alone and with a program - JOSPT 2026 meta-analysis 1 row · trial outcomes - Lai et al. 2022, Nursing & Health Sciences 1 row · sleep - Zhu et al. 2026, JMIR 1 row · sleep - Comas et al., RCT with actigraphy 1 row · sleep - Hartman et al. 2022, JMIR mHealth 2 rows · tracker alone and with a program - Duolingo Q2 2026 shareholder letter 3 rows · Duolingo tie-in A company’s own figures
THE PROCESS
[01] One row per figure
Each figure went into a row of its own with a source name, a URL, the date I retrieved
it and a flag for whether the company reported it. That came to 74 rows in metrics.csv
from 39 source pages.
[02] Parse
51 of the 74 rows have a comma inside a field, such as “Met aerobic physical activity
guideline, age-adjusted”. Both files also use CRLF line endings. The parser reads
quoted fields cell by cell and drops the carriage returns.
[03] Join
Wearable use comes from HINTS and the activity guideline comes from NHIS. I joined the
two on year. Both cover 2020 and 2024, and only HINTS has a 2022 figure.
[04] Assumptions
Some sources gave a figure in words. Whoop’s member count was “more than 2.5M” and went
in as 2.5. Oura’s share of first-time wearable buyers was “about a third” and went in
as 33. Rows M01 to M03, the umbrella review’s extra steps and minutes a day, are marked
approximate. The HINTS abstract gives daily use without naming its base. The table
reads it as a share of all adults, so daily use stays out of the findings on this page.
[05] Check
Oura’s nine-month revenue shows up in several press reports, so I checked it two ways.
Hardware plus membership comes to $1,214.5 million against $1,210 million reported.
Fiscal 2025 plus the nine-month change gives $1,420.3 million for the trailing year
against $1,430 million reported. The larger gap is 0.7%, which fits rounding in the
coverage.
# One year before and after the join.
- Before, three rows of metrics.csv (six of 12 columns shown)
- After, one row per year
The first two rows are HINTS and the third is NHIS. The comma inside the third metric name
is why the parser reads quoted fields.
# The code for the key steps
- The parser, which handles commas inside quoted fields and CRLF line endings.
derive.mjs ........ /studies/oura-and-whoop/derive.mjs
- The join between the HINTS rows and the NHIS rows, by year.
derive.mjs ........ /studies/oura-and-whoop/derive.mjs
- The headline changes and shares.
derive.mjs ........ /studies/oura-and-whoop/derive.mjs
# Dead ends
google trends ....... I left Google Trends out because the research workspace could not
reach it.
no 2022 point for activity
The Healthy People page has no 2022 value for the aerobic guideline.
The 2022 wearable figure of 36.36% comes from a separate analysis of
the same HINTS survey, so the comparison runs from 2020 to 2024.THE 3 FINDINGS THAT CHANGE THE DECISION
[01] +0.1 points · Change in adults meeting the aerobic guideline, 2020 to 2024
From 2020 to 2024 the share of US adults using a wearable rose from 30.2% to 41.1%, and
the share meeting the aerobic activity guideline went from 47.9% to 48.0%.
dataset .......... metrics.csv
query ............ derive.mjs, trend()
# Wearable use rose from 30.2% to 41.1%. The share meeting the activity guideline moved
0.1 points
Wearable use is from HINTS. Meeting the aerobic guideline is from NHIS, age-adjusted.
They are two different surveys, and population totals cannot show what happens to one
user. NHIS has no 2022 value on the Healthy People page, so each line has two points.
year ............. Share of US adults (%)
meet the aerobic guideline
2020 47.9, 2024 48.0
use a wearable ... 2020 30.2, 2024 41.1
source ........... metrics.csv, derive.mjs, trend()
[02] 54% · Share of the end-of-program walking effect left at long follow-up
In a meta-analysis of mobile health activity trials, only 54% of the walking effect was
left at follow-ups more than six months after a program ended.
dataset .......... metrics.csv
query ............ derive.mjs, headline()
# Only 54% of the walking effect is left after a program ends
Standardized mean difference (SMD) against control, pooled in one meta-analysis
(Monninghoff et al. 2021, JMIR). Around 0.2 is small and 0.5 is medium. Few trials
report long follow-up, so the later bars rest on less data.
When the effect was measured ..................... Walking effect against control (SMD)
End of program ................................................................... 0.46
Moderate-to-vigorous activity effect (SMD): 0.28 · Trials behind it: 117 mHealth
trials
Up to 6 months after ............................................................. 0.26
Moderate-to-vigorous activity effect (SMD): 0.20 · Trials behind it: 33 trials with
short follow-up
More than 6 months after ......................................................... 0.25
Moderate-to-vigorous activity effect (SMD): 0.19 · Trials behind it: 8 trials with
long follow-up
source ........... metrics.csv, derive.mjs, fade()
[03] 1.9x · Activity gain with a program around the tracker over the tracker alone, 0.33
against 0.17 SMD
Trials that put a program around the tracker raised moderate-to-vigorous activity about
twice as much as the tracker alone. The tracker-alone result was too small to rule out
chance.
dataset .......... metrics.csv
query ............ derive.mjs, design()
# A program around the tracker moved activity about twice as much as the tracker alone
Subgroups of one review of consumer trackers (Brickwood et al. 2019, JMIR mHealth).
Each group was compared with a control group, and the tracker-alone result was not
statistically significant. SMD is the standardized mean difference, where around 0.2 is
small and 0.5 is medium. In the review a program meant added support such as counseling
or financial incentives. Trackers that came with app messages or emails counted as
tracker alone.
Outcome and design ....................................... Effect against control (SMD)
MVPA, tracker plus program ....................................................... 0.33
Source row: M16 · Note in the table: None
MVPA, tracker alone .............................................................. 0.17
Source row: M15 · Note in the table: Not significant (P = .05)
Daily steps, tracker plus program ................................................ 0.26
Source row: M14 · Note in the table: None
Daily steps, tracker alone ....................................................... 0.20
Source row: M13 · Note in the table: 28 RCTs, 3,646 adults
source ........... metrics.csv, derive.mjs, design()MY RECOMMENDATION
Turn Advisor into a weekly plan, and publish how many members sleep or move more after 90 days. [A] Turn Advisor into a weekly plan Each week Advisor picks one behavior from the member’s own sleep and Readiness data. It sets a target for that week and checks in midway. evidence ......... Findings 2 and 3. Trials that put a program around the tracker raised moderate-to-vigorous activity about twice as much as the tracker alone, and the walking effect fades once a program ends. On my 0-to-2 scale for coaching, Oura scores 1 and Whoop and Fitbit score 2. main risk ........ That result comes from subgroups of one review, and the tracker-alone result beside it was not significant. The programs in that review added support such as counseling or financial incentives. App messages counted as tracker alone, so an Advisor plan may land nearer the tracker-alone result. [B] Publish a behavior-change number Report the share of members whose sleep time or active minutes improved after 90 days, beside the 85% retention figure. evidence ......... Finding 1 and Oura’s own funnel. Oura reports 3.6 million rings sold in a year, 94% of activations turning into paid members, 85% of paid members kept for a year and a median 23 hours a day of wear. Its closest figure to an outcome is a survey where 56% of Advisor users said it helped them act. main risk ........ Oura would report the number itself. 19 of the 22 Oura rows in this study already come from the company, and the 56% survey has no outcome data behind it. - Two findings back the weekly plan. A program around the tracker moved activity about twice as much as the tracker alone, and the effect faded once the program ended, so the plan has to keep running. - The 90-day number tells Oura and its members whether the plan works. Today the closest thing Oura has is a survey where members said Advisor helped. - That number should go out with its method, since Oura would be grading itself.
LIMITS AND NEXT STEPS
# What the data cannot support
- Population totals cannot show what happens to one user, and wearable use and the
activity guideline come from two different surveys.
- No row here compares people who pay a subscription with people who do not, and none of
the trial rows names Oura or Whoop.
- The Oura rows cite press coverage of the S-1. I found no behavior outcome in that
coverage, which is a weaker claim than saying the filing has none.
- 31 of the 74 rows in metrics.csv are flagged as reported by the company they describe,
including every Oura engagement figure.
- Finding 2 compares different sets of trials. The end-of-program effect pools 117 mHealth
trials, and the later points rest on 33 trials with short follow-up and 8 trials with
long follow-up.
- The feature scores are my own judgment.
- Every row was retrieved on October 31, 2026, so nothing after that date is here.
# What I would test with more access
- With HINTS microdata and survey weights I would link wearable use and activity for the
same person.
- With Oura’s own data I would measure the number option B asks for, the share of members
whose sleep time or active minutes improved after 90 days.
- I would add Google Trends search interest, which I could not reach, and source the Oura
rows from the S-1 itself.TL;DR
studied ............... Whether paying for a wearable changes how people live, read from US surveys and activity trials. found ................. From 2020 to 2024, wearable use rose from 30.2% to 41.1% and adults meeting the activity guideline went from 47.9% to 48.0%. # by the numbers +0.1 points ......... Change in adults meeting the guideline 54% ................. Of the walking effect left at long follow-up 85% ................. Paid Oura members kept for a year the catch ............. Wearable use and the activity guideline come from two different surveys, so neither shows what one user did. next .................. With person-level HINTS survey data, link wearable use and activity for the same person.
# end of /machine/oura-and-whoop. andrew.leng.ly@gmail.com · leave machine mode